CALASTRETTI, ANGELA LUISA
CALASTRETTI, ANGELA LUISA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells
2018 A. Calastretti, G. Gatti, V. Lucini, S. Dugnani, G. Canti, F. Scaglione, A. Bevilacqua
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells
2017 G. Gatti, V. Lucini, S. Dugnani, A. Calastretti, G. Spadoni, A. Bedini, S. Rivara, M. Mor, G. Canti, F. Scaglione, A. Bevilacqua
Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes
2014 A. Calastretti, G. Gatti, C. Quaresmini, A. Bevilacqua
Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia
2010 G. Canti, A.L. Calastretti, A.T. Bevilacqua, E. Reddi, G. Palumbo, A.N. Nicolin
B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity
2009 L. Ghisolfi, A. Calastretti, S. Franzi, G. Canti, M. Donnini, S. Capaccioli, A. Nicolin, A. Bevilacqua
Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles
2007 P. Bruno, A. Calastretti, M. Priulla, L. Asnaghi, F. Scarlatti, A. Nicolin, G. Canti
Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase
2007 M. Priulla, A. Calastretti, P. Bruno, A. Azzariti, A. Paradiso, G. Canti, A. Nicolin
Terapia fotodinamica e nuovi fotosensibilizzanti
2005 G. Canti, L.A. Calastretti
Antitumor activity of photodynamic therapy, adoptive immunotherapy, and chemotherapy in experimental tumor
2004 G. Canti, A. Calastretti, R. Cubeddu, P. Tironi, G. Valentini, E. Reddi, G. Palumbo
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt
2004 L. Asnaghi, A.L. Calastretti, A.T. Bevilacqua, I. D’Agnano, G. Gatti, G. Canti, S. Capaccioli, A.N. Nicolin
Fotoimmunologia. In Fotodermatologia
2003 G. Canti, A. De Simone, A. Calastretti
Inhibition of tumor cell proliferation by linear polyunsaturated aldehydes
2003 A. Calastretti, A. Bevilacqua, G. Canti, C. Testorelli, L. Asnaghi, A. Nicolin, A. Bertelli
Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect
2001 A. Calastretti, F. Rancati, M. C. Ceriani, L. Asnaghi, G. Canti, A. Nicolin
Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase
2001 A. Calastretti, A. Bevilacqua, C. Ceriani, S. Viganò, P. Zancai, S. Capaccioli, A. Nicolin
Synthetic antisense oligonucleotides: Principles and antileukemic activity
1997 S. Morelli, A. Quattrone, N. Schiavone, A.L. Calastretti, A.T. Bevilacqua, S. Tomasini, A.N. Nicolin
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines
1996 S. Capaccioli, A. Quattrone, N. Schiavone, A. Calastretti, E. Copreni, A. Bevilacqua, G. Canti, L. Gong, S. Morelli, A. Nicolin